Company news

Harmony Biosciences Holdings, Inc. news in 2022

Harmony Biosciences Holdings, Inc.'s news releases, calls and decks from 2022, newest first.

View company

Harmony Biosciences to present at the 41st annual j.p. morgan healthcare conference

December 21, 2022

Harmony Biosciences to participate in Piper Sandler 34th annual healthcare conference

November 8, 2022

Harmony Biosciences Reports Third Quarter 2022 Financial Results and Business Updates

October 31, 2022

Harmony Biosciences announces topline results from phase 2 proof-of-concept study evaluating pitolisant for excessive daytime sleepiness in patients with Prader-Willi syndrome

October 31, 2022

Harmony Biosciences to report third quarter 2022 financial results on November 1, 2022

October 17, 2022

Harmony Biosciences announces 2022 funding recipients of Patients at the Heart and Progress at the Heart award programs

September 21, 2022

Harmony Biosciences Reports Second Quarter 2022 Financial Results and Business Updates

August 1, 2022

Harmony Biosciences announces date of second quarter 2022 financial results

July 18, 2022

Harmony Biosciences presents post-hoc analysis of WAKIX® (pitolisant) pivotal data in adults with high burden of narcolepsy symptoms

June 5, 2022

Harmony Biosciences Reports First Quarter 2022 Financial Results and Business Updates

May 2, 2022

Harmony Biosciences initiates Phase 3 trial of pitolisant in adult patients with idiopathic hypersomnia

April 26, 2022

Harmony Biosciences announces date of first quarter 2022 financial results

April 18, 2022

Harmony Biosciences opens applications for 2022 Progress at the Heart program

April 6, 2022

Harmony Biosciences to participate in 21st annual needham virtual healthcare conference

April 3, 2022

Harmony Biosciences certified as a Great Place to Work® for fourth consecutive year

March 30, 2022

Harmony Biosciences announces applications open March 18 for 2022 Patients at the Heart program

March 16, 2022

Harmony Biosciences to participate in two investor conferences in March

March 8, 2022

Harmony Biosciences Reports Fourth Quarter and Full Year 2021 Financial Results and Business Updates

February 27, 2022

Harmony Biosciences Announces Date of Fourth Quarter and Full Year 2021 Financial Results

February 13, 2022

Harmony Biosciences to Participate in 40th Annual J.P. Morgan Healthcare Conference

January 4, 2022

Calls in 2022

Decks in 2022